News
Talking lung cancer with University of Minnesota
Lung cancer remains the leading cause of cancer death in Minnesota that opens in the same window, but advances in screening and treatment are helping improve outcomes for patients.
UMN-Mayo partnership marks two years of progress toward stronger cancer immunotherapies
Two years ago, researchers from the University of Minnesota’s Masonic Cancer Center and Center for Genome Engineering joined researchers from Mayo Clinic Comprehensive Cancer Center to tackle an ambitious question: How can we help the…
New NCI grant marks milestone for Masonic Cancer Center's prostate cancer research
The Masonic Cancer Center, University of Minnesota, together with the Mayo Clinic Comprehensive Cancer Center have received a Specialized Program of Research Excellence (SPORE) grant in Prostate Cancer from the National Cancer Institute…
Long and interstate travel may be a barrier to care for certain pediatric care patients
Patients with the greatest social vulnerability were least likely to cross state lines to receive medical care.
Could a treatment developed for multiple myeloma change care for AL amyloidosis?
CAR-T cell therapy has changed how doctors treat some blood cancers, including multiple myeloma. Now, researchers are wondering if this same approach might help people with AL amyloidosis, a rare blood disease caused by abnormal plasma…
Masonic Cancer Center announces new leadership for the Minnesota Cancer Clinical Trials Network
The Masonic Cancer Center (MCC), University of Minnesota is pleased to announce the appointment of Melissa Geller, MD, MS, and Rebekah Pratt, PhD, as co-medical directors of the Minnesota Cancer Clinical Trials Network (MNCCTN)…
Masonic Cancer Center announces new Data Sciences leadership
The Masonic Cancer Center (MCC), University of Minnesota is pleased to announce the appointment of J. Sunil Rao, PhD, and Schelomo Marmor, PhD, MPH, as co-associate directors of Data Sciences. Justin Hwang, PhD, has also been named…
Masonic Cancer Center announces new leadership for cancer research training and education
The Masonic Cancer Center (MCC), University of Minnesota is pleased to announce new leadership appointments in Cancer Research Training and Education Coordination (CRTEC). Martin Felices, PhD, was named associate director of CRTEC in April…
Masonic Cancer Center welcomes Scott Dehm as co-leader of the Genomics, Cell States, and Signaling Program
The Masonic Cancer Center, University of Minnesota is pleased to announce that Scott Dehm, PhD, was named co-leader of the Genomics, Cell States, and Signaling (GCSS) research program in April 2026. Dehm joins R.
Masonic Cancer Center announces inaugural Illuminate Gala to advance cancer research through philanthropy
The Masonic Cancer Center (MCC), University of Minnesota has announced its inaugural Illuminate Gala, a fundraising event dedicated to advancing cancer research through philanthropic investment and partnership.Taking place on September 24,…